Cleared Traditional

K022833 - BENJAMIN ENVOY PHACO HANDPIECE

K022833 is an FDA 510(k) clearance for BENJAMIN ENVOY PHACO HANDPIECE, manufactured by Benjamin Biomedical, Inc.. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 14-day FDA review.

K022833 · Benjamin Biomedical, Inc. · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2002
Decision
14d
Days
Class 2
Risk

K022833 is an FDA 510(k) clearance for the BENJAMIN ENVOY PHACO HANDPIECE. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Benjamin Biomedical, Inc. (Appollo Beach, US). The FDA issued a Cleared decision on September 9, 2002 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Benjamin Biomedical, Inc. devices

FDA 510(k) Submission Details - K022833

510(k) Number K022833 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 26, 2002
Decision Date September 09, 2002
Days to Decision 14 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 110d · This submission: 14d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 190
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K022833.
BAUSCH & LOMB NGX MICROSURGICAL SYSTEM
K063331 · Bausch & Lomb, Inc. · Dec 2006
PHACO CHOP NEEDLES
K041998 · Bausch & Lomb, Inc. · Aug 2004
VENTURI PHACO PACK
K033653 · Bausch & Lomb, Inc. · Dec 2003
INFINITI
K021566 · Alcon Laboratories, Inc. · Jul 2002
SURGE-FREE ASPIRATION ADAPTER
K020734 · Staar Surgical Co. · May 2002
MOJAVE CATARACT EXTRACTION SYSTEM
K003638 · Allergan, Inc. · Feb 2001